文献速递胃肠外科

直肠癌腹腔镜与机器人低位前切除术对比开腹的倾向匹配分析

Outcomes in rectal cancer patients undergoing laparoscopic or robotic low anterior resection compared to open: a propensity-matched analysis of the NCDB (2010-2015).
PubMed 文献 · Surg Endosc · 2019-11-14

基于美国国家癌症数据库2010-2015年数据,对26047例直肠癌低位前切除术患者进行倾向评分匹配,比较机器人、腹腔镜与开腹手术的围手术期结局和总生存。匹配后显示切缘阳性率、住院时间和再入院率存在小幅差异,三种手术方式的结局均可接受。

要点

  • 微创与开腹低位前切除术的切缘阳性率、住院时间和总生存差异较小。
  • 腹腔镜和机器人手术中转开腹率分别为15%和8%。
  • 在倾向匹配队列中,三种术式的肿瘤学结局均在可接受范围。

核心结论

  • 在倾向匹配的直肠癌低位前切除术患者中,开腹、腹腔镜和机器人手术在切缘状态、住院时间、再入院和总生存方面仅显示小幅差异。
  • 尽管存在选择偏倚,数据表明所评估的每种手术技术均可为直肠癌患者带来可接受的结局。

研究设计与样本

  • 使用美国国家癌症数据库(NCDB)2010-2015年数据,对直肠癌低位前切除术患者进行倾向评分匹配分析。
  • 共26047例患者接受低位前切除术:机器人4062例(16%),腹腔镜9236例(35%),开腹12749例(49%)。

主要发现

  • 腹腔镜和机器人手术的中转开腹率分别为15%和8%。
  • 匹配的开腹与腹腔镜患者中,纵向切缘阳性率分别为5.4%和3.2%(p<0.001),环周切缘阳性率分别为5.5%和4.1%(p<0.001),住院时间分别为6天和5天(p<0.001),再入院率分别为6.5%和7.0%(p=0.112),1年、3年和5年总生存率分别为95.5%、83.7%、72.0%和95.9%、86.3%、76.4%(p<0.001)。
  • 匹配的开腹与机器人患者中,纵向切缘阳性率分别为5.4%和3.2%(p<0.001),环周切缘阳性率分别为5.5%和3.9%(p<0.001),住院时间分别为6天和5天(p<0.001),再入院率分别为6.1%和7.9%(p=0.010),1年、3年和5年总生存率分别为96.2%、86.5%、77.1%和97.5%、89.4%、79.7%(p=0.001)。

临床怎么用

  • 对于适合低位前切除术的直肠癌患者,腹腔镜或机器人手术可作为开腹手术的合理替代选择。
  • 需结合患者具体情况和术者经验选择术式,并注意微创手术的中转开腹风险。

局限性

  • 研究为回顾性分析,存在选择偏倚。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive resection of rectal cancer is controversial due to concerns of the oncologic efficacy and the difficulties of a laparoscopic total mesorectal excision (TME). METHODS: Using the National Cancer Database (NCDB), for the period 2010-2015, perioperative outcomes and overall survival (OS) in patients with rectal cancer who underwent laparoscopic or robotic low anterior resection (LLAR or RLAR) were compared to open LAR (OLAR) after propensity score matching. RESULTS: 26,047 patients underwent LAR: 4062 (16%) RLAR, 9236 (35%) LLAR, and 12,749 (49%) OLAR. Patient and clinical tumor characteristics were similar between groups after matching. The conversion rates among patients undergoing LLAR and RLAR were 15% and 8%, respectively. In matched OLAR and LLAR patients, longitudinal and circumferential resection margins (CRM) were positive in 5.4% and 3.2% (p < 0.001) and 5.5% and 4.1% (p < 0.001); length of stay was 6 and 5 days, (p < 0.001); readmission was required in 6.5% and 7.0% (p = 0.112); OS at 1, 3, and 5 years were 95.5%, 83.7%, and 72.0% and 95.9%, 86.3%, and 76.4%, respectively (p < 0.001). In matched OLAR and RLAR patients, longitudinal and CRM were positive in 5.4% and 3.2% (p < 0.001) and 5.5% and 3.9% (p < 0.001); length of stay was 6 and 5 days (p < 0.001); readmission was required in 6.1% and 7.9%, (p = 0.010); and OS at 1, 3, and 5 years were 96.2%, 86.5%, and 77.1% and 97.5%, 89.4%, and 79.7%, respectively (p = 0.001). CONCLUSIONS: In this national sample of propensity matched patients with rectal cancer who underwent open, laparoscopic, or robotic sphincter-saving rectal resection, only small differences in terms of resection margin status, length of stay, readmission, and overall survival were revealed. With acknowledgement of the limitations introduced by selection bias, our data indicate that each of the evaluated operative techniques results in acceptable outcomes for patients with rectal cancer.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Chapman BC, Edgcomb M, Gleisner A, et al. Outcomes in rectal cancer patients undergoing laparoscopic or robotic low anterior resection compared to open: a propensity-matched analysis of the NCDB (2010-2015). Surg Endosc. 2019. PMID: 31728754. doi:10.1007/s00464-019-07252-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。